Chan F K
Building 10, Room 11N311, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1892, USA.
Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i50-3. doi: 10.1136/ard.59.suppl_1.i50.
Signalling by the tumour necrosis factor receptors (TNFR) is thought to be mediated by the binding of the trimeric ligand TNF to three monomeric subunits of the receptor. This ligand induced trimerisation model of TNFR signalling is mainly supported by crystallographic data of the p60 TNFR-1 and TNFbeta complex in which the trimeric ligand interdigitates between the individual receptor chains and prevents the receptor subunits from interacting with each other. Recently, a domain NH(2)-terminal to the ligand binding domain in the extracellular region of p60 TNFR-1, p80 TNFR-2 and Fas was identified that mediates receptor self association before ligand binding. This pre-ligand binding assembly domain or PLAD is critical for assembly of functional receptor complexes on the cell surface and may provide a potential target in the design of future novel therapeutics against diseases mediated by members of the TNFR family of receptors.
肿瘤坏死因子受体(TNFR)的信号传导被认为是由三聚体配体TNF与受体的三个单体亚基结合介导的。TNFR信号传导的这种配体诱导三聚化模型主要得到p60 TNFR-1和TNFβ复合物晶体学数据的支持,其中三聚体配体在各个受体链之间相互交错,阻止受体亚基相互作用。最近,在p60 TNFR-1、p80 TNFR-2和Fas的细胞外区域中,在配体结合结构域的NH(2)-末端鉴定出一个结构域,该结构域在配体结合之前介导受体自缔合。这种配体结合前组装结构域或PLAD对于细胞表面功能性受体复合物的组装至关重要,并且可能为未来设计针对TNFR受体家族成员介导的疾病的新型治疗药物提供潜在靶点。